Loading…
Angiplast Private Limited, a medical device manufacturer, received an FDA Warning Letter on May 14, 2020. Based on the limited metadata available, the specific nature of the violations cannot be determined as no subject line was provided. The warning pertains to medical devices under FDA regulatory authority, though the specific issuing office and violation details are not available in this metadata summary.